{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:53:05Z","timestamp":1788897185175,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University Sapienza research","award":["RM12117A8ABD4220"],"award-info":[{"award-number":["RM12117A8ABD4220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Myocardial scarring assessed by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) predicts sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM). Post-processing enables characterization of scar components: borderzone (BZ), core, and BZ channels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Evaluate scar composition as a predictor of VT\/VF beyond traditional risk factors in HCM. We retrospectively analyzed HCM patients who underwent LGE-CMR. Scar components, alone or combined with ESC or ACC\/AHA risk scores, were tested as predictors of a composite VT\/VF endpoint (SCD, sustained VT, ICD therapy, or cardiac arrest). Four-hundred-ten patients (67% males, 55 years IQR: 41\u201365) were included, 298 of whom (72.6%) had LGE at CMR (LGE+). Total scar, BZ and core mass were 7.3% (IQR: 0.0\u201314.3), 6.4% (IQR: 0.0\u201312.2), and 0.9% (IQR: 0.0\u20132.1) of LV mass, respectively. BZ channels were found in 140 (34.1%) patients. At follow-up (65 months; IQR: 36\u201395), 26 (6.3%) patients met the endpoint. Total scar, BZ and core mass were higher in VT\/VF patients (P &amp;lt; 0.001). BZ channels were observed in 88.5% of VT\/VF patients vs. 30.5% of those without (P &amp;lt; 0.001). Patients with BZ channels had higher incidence of VT\/VF. BZ channels mass was associated with an increased risk of VT\/VF after adjustment for ESC (HR: 1.45; 95% CI: 1.26\u20131.67; P &amp;lt; 0.0001) and AHA\/ACC (HR: 1.34; 95% CI: 1.16\u20131.54; P &amp;lt; 0.0001) risk estimate. The predictive performance of both ESC and AHA\/ACC models was enhanced by integrating BZ channel mass (NRI: 0.19, P = 0.03 and 0.32, P &amp;lt; 0.001, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Scar composition and its organization in BZ channels provides strong, independent prognostic value for VT\/VF in HCM, improving existing clinical risk stratification tools.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeaf297","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:14:03Z","timestamp":1761671643000},"page":"400-412","source":"Crossref","is-referenced-by-count":5,"title":["Scar architecture as a structural biomarker of ventricular arrhythmias and sudden cardiac death in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0306-7764","authenticated-orcid":false,"given":"Pietro","family":"Francia","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Cardiology Unit, Sant\u2019Andrea University Hospital, University Sapienza , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-9911","authenticated-orcid":false,"given":"Giulio","family":"Falasconi","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, Teknon Heart Institute, Teknon Medical Center , Calle Villana 12 (08022), Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Musumeci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Cardiology Unit, Sant\u2019Andrea University Hospital, University Sapienza , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-0440","authenticated-orcid":false,"given":"Elena","family":"Biagini","sequence":"additional","affiliation":[{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Bologna ,","place":["Italy"]},{"name":"Cardiac Thoracic and Vascular Department, Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Freitas","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7221-4829","authenticated-orcid":false,"given":"Diego","family":"Penela","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital , Department of Biomedical Sciences, Humanitas University, Rozzano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ortiz-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Institut D'Investigacions Biom\u00e8diques August Pi I Sunyer (IDIBAPS) , Barcelona ,","place":["Spain"]},{"name":"Acute Cardiac Care Section, Cardiovascular Institute, Hospital Cl\u00ednic , Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Tini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Cardiology Unit, Sant\u2019Andrea University Hospital, University Sapienza , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Sclafani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Cardiology Unit, Sant\u2019Andrea University Hospital, University Sapienza , Rome ,","place":["Italy"]},{"name":"Royal Brompton and Harefield Hospitals, Guy\u2019s and St Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Alessandra","family":"Schiavo","sequence":"additional","affiliation":[{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Bologna ,","place":["Italy"]},{"name":"Cardiac Thoracic and Vascular Department, Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6322-733X","authenticated-orcid":false,"given":"Rita","family":"Amador","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental , Lisbon ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Carli","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital , Department of Biomedical Sciences, Humanitas University, Rozzano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"del Monaco","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital , Department of Biomedical Sciences, Humanitas University, Rozzano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9198-3676","authenticated-orcid":false,"given":"Cristina","family":"Panico","sequence":"additional","affiliation":[{"name":"IRCCS Humanitas Research Hospital , Department of Biomedical Sciences, Humanitas University, Rozzano ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1394-6260","authenticated-orcid":false,"given":"David","family":"Soto-Iglesias","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, Teknon Heart Institute, Teknon Medical Center , Calle Villana 12 (08022), Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6157-058X","authenticated-orcid":false,"given":"Paula","family":"Franco-Oca\u00f1a","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, Teknon Heart Institute, Teknon Medical Center , Calle Villana 12 (08022), Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaello","family":"Ditaranto","sequence":"additional","affiliation":[{"name":"European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart , Bologna ,","place":["Italy"]},{"name":"Cardiac Thoracic and Vascular Department, Cardiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-1507","authenticated-orcid":false,"given":"Andrea","family":"Saglietto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardiovascular and Thoracic Department, \u2018Citta Della Salute e Della Scienza\u2019 Hospital , Turin ,","place":["Italy"]},{"name":"Department of Medical Sciences, University of Turin , Turin ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Mart\u00ec-Almor","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, Teknon Heart Institute, Teknon Medical Center , Calle Villana 12 (08022), Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Autore","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular and Respiratory Sciences, San Raffaele , Cassino, FR ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5418-383X","authenticated-orcid":false,"given":"Antonio","family":"Berruezo","sequence":"additional","affiliation":[{"name":"Arrhythmia Department, Teknon Heart Institute, Teknon Medical Center , Calle Villana 12 (08022), Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2026022618523104100_jeaf297-B1","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.amjcard.2012.05.064","article-title":"Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy","volume":"110","author":"Greulich","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026022618523104100_jeaf297-B2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N Engl J Med"},{"key":"2026022618523104100_jeaf297-B3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2026022618523104100_jeaf297-B4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2009.04.026","article-title":"Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia","volume":"54","author":"Kwon","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026022618523104100_jeaf297-B5","doi-asserted-by":"crossref","first-page":"758635","DOI":"10.3389\/fcvm.2021.758635","article-title":"Mean scar entropy by late gadolinium enhancement cardiac magnetic resonance is associated with ventricular arrhythmias events in hypertrophic cardiomyopathy","volume":"8","author":"Ye","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026022618523104100_jeaf297-B6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCIMAGING.111.963819","article-title":"Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy","volume":"5","author":"Appelbaum","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B7","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026022618523104100_jeaf297-B8","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026022618523104100_jeaf297-B9","doi-asserted-by":"crossref","first-page":"e010489","DOI":"10.1161\/CIRCIMAGING.120.010489","article-title":"Late gadolinium enhancement-dispersion mapping: a new magnetic resonance imaging technique to assess prognosis in patients with hypertrophic cardiomyopathy and low-intermediate 5-year risk of sudden death","volume":"13","author":"Aquaro","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcmg.2023.05.003","article-title":"Radiomics of late gadolinium enhancement reveals prognostic value of myocardial scar heterogeneity in hypertrophic cardiomyopathy","volume":"17","author":"Fahmy","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B11","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.jacc.2010.01.052","article-title":"Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events","volume":"55","author":"Heidary","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026022618523104100_jeaf297-B12","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jcmg.2017.04.021","article-title":"Scar characterization to predict life-threatening arrhythmic events and sudden cardiac death in patients with cardiac resynchronization therapy: the GAUDI-CRT study","volume":"11","author":"Acosta","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/europace\/euab275","article-title":"Cardiovascular magnetic resonance determinants of ventricular arrhythmic events after myocardial infarction","volume":"24","author":"J\u00e1uregui","year":"2021","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jcmg.2023.03.016","article-title":"Substrates of scar-related ventricular arrhythmia in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study","volume":"16","author":"Francia","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B15","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur Heart J"},{"key":"2026022618523104100_jeaf297-B16","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice Guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"2026022618523104100_jeaf297-B17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/europace\/euu310","article-title":"3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation","volume":"17","author":"Andreu","year":"2015","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/CIRCEP.113.000264","article-title":"Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: insights for ventricular tachycardia ablation","volume":"6","author":"Fern\u00e1ndez-Armenta","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026022618523104100_jeaf297-B19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/europace\/euz118","article-title":"A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"21","author":"Norrish","year":"2019","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B20","doi-asserted-by":"crossref","first-page":"e005820","DOI":"10.1161\/CIRCEP.117.005820","article-title":"Clinical course and quality of life in high-risk patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators","volume":"11","author":"Maron","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026022618523104100_jeaf297-B21","doi-asserted-by":"crossref","first-page":"euad270","DOI":"10.1093\/europace\/euad270","article-title":"Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator","volume":"25","author":"Francia","year":"2023","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B22","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/europace\/euab309","article-title":"Implantable cardioverter-defibrillators for hypertrophic cardiomyopathy: the times they are a-changin\u2019","volume":"24","author":"Francia","year":"2021","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B23","doi-asserted-by":"crossref","first-page":"euae050","DOI":"10.1093\/europace\/euae050","article-title":"Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy","volume":"26","author":"Francia","year":"2024","journal-title":"Europace"},{"key":"2026022618523104100_jeaf297-B24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/hupa.2000.16659","article-title":"Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia","volume":"31","author":"Basso","year":"2000","journal-title":"Hum Pathol"},{"key":"2026022618523104100_jeaf297-B25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0735-1097(03)00189-X","article-title":"Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance","volume":"41","author":"Moon","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026022618523104100_jeaf297-B26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.77.3.589","article-title":"Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation","volume":"77","author":"de Bakker","year":"1988","journal-title":"Circulation"},{"key":"2026022618523104100_jeaf297-B27","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.hrthm.2024.04.077","article-title":"Predicting postinfarct ventricular tachycardia by integrating cardiac MRI and advanced computational reentrant pathway analysis","volume":"21","author":"Bhagirath","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2019.03.060","article-title":"Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy","volume":"291","author":"Fo\u00e0","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026022618523104100_jeaf297-B29","doi-asserted-by":"crossref","first-page":"e101465","DOI":"10.1371\/journal.pone.0101465","article-title":"High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy","volume":"9","author":"Konno","year":"2014","journal-title":"PLoS One"},{"key":"2026022618523104100_jeaf297-B30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jcmg.2012.09.018","article-title":"Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR","volume":"6","author":"Moravsky","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jcmg.2022.10.020","article-title":"Comprehensive phenotypic characterization of late gadolinium enhancement predicts sudden cardiac death in coronary artery disease","volume":"16","author":"Jones","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B32","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2010.05.007","article-title":"Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy","volume":"56","author":"Bruder","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026022618523104100_jeaf297-B33","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.hrthm.2021.12.017","article-title":"Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy:an international multicenter study","volume":"19","author":"Rowin","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B34","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3390\/jcm14041331","article-title":"Substrates of sudden cardiac death in hypertrophic cardiomyopathy","volume":"14","author":"Sclafani","year":"2025","journal-title":"J Clin Med"},{"key":"2026022618523104100_jeaf297-B35","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.hrthm.2015.02.004","article-title":"Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy","volume":"12","author":"Sakamoto","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B36","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fphys.2020.00344","article-title":"Mechanisms of arrhythmogenicity in hypertrophic cardiomyopathy: insight from non-invasive electrocardiographic imaging","volume":"11","author":"Perez-Alday","year":"2020","journal-title":"Front Physiol"},{"key":"2026022618523104100_jeaf297-B37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.109.854026","article-title":"Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy","volume":"3","author":"Rubinshtein","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026022618523104100_jeaf297-B38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.hlc.2008.03.080","article-title":"Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients","volume":"17","author":"Suk","year":"2008","journal-title":"Heart Lung Circ"},{"key":"2026022618523104100_jeaf297-B39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","article-title":"Quantitative late gadolinium enhancement cardiac magnetic resonance and sudden death in hypertrophic cardiomyopathy: a meta-analysis","volume":"17","author":"Kiaos","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B40","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/cvr\/cvaa124","article-title":"Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy","volume":"116","author":"Coppini","year":"2020","journal-title":"Cardiovasc Res"},{"key":"2026022618523104100_jeaf297-B41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jcmg.2020.09.037","article-title":"Progression of myocardial fibrosis in hypertrophic cardiomyopathy: a cardiac magnetic resonance study","volume":"14","author":"Habib","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026022618523104100_jeaf297-B42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2023.11.003","article-title":"Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy","volume":"211","author":"Aquaro","year":"2024","journal-title":"Am J Cardiol"},{"key":"2026022618523104100_jeaf297-B43","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.hrthm.2025.03.1943","article-title":"Optimizing ventricular scar characterization in late-gadolinium enhancement cardiac MRI: impact of thresholding techniques in magnitude and phase-sensitive reconstructed images","volume":"22","author":"Burger","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B44","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.hrthm.2022.05.021","article-title":"Predicting arrhythmia recurrence following catheter ablation for ventricular tachycardia using late gadolinium enhancement magnetic resonance imaging: implications of varying scar ranges","volume":"19","author":"Bhagirath","year":"2022","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B45","doi-asserted-by":"publisher","first-page":"S1547-5271(25)02921-2","DOI":"10.1016\/j.hrthm.2025.09.028","article-title":"Ventricular tachycardia substrate mapping with cardiac computed tomography and cardiac magnetic resonance imaging: head-to-head comparison of two clinically available postprocessing platforms","author":"Laan","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026022618523104100_jeaf297-B46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.hlc.2021.04.008","article-title":"Fibrosis in hypertrophic cardiomyopathy patients with and without sarcomere gene mutations","volume":"30","author":"Vullaganti","year":"2021","journal-title":"Heart Lung Circ"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf297\/65006547\/jeaf297.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/3\/400\/65006547\/jeaf297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/27\/3\/400\/65006547\/jeaf297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:52:44Z","timestamp":1772149964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/3\/400\/8305360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,28]]},"published-print":{"date-parts":[[2026,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf297","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,10,28]]}}}